Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz Messerli

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of the American Society of Hypertension : JASH|September 7, 2012
Ambulatory blood pressure monitoring should be included in the National Health and Nutritional Examination Survey (NHANES)Thomas D Giles, Henry R Black, Franz Messerli, et al.
Current Pharmaceutical Design|May 30, 2006
Target organ damage in hypertension: pathophysiology and implications for drug therapySunil K Nadar, Muzahir H Tayebjee, Franz Messerli, et al.
Hypertension (Dallas, Tex. : 1979)|July 4, 2007
Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril StudyGiuseppe Mancia, Franz Messerli, George Bakris, et al.
American Heart Journal|November 18, 2022
Impact of design characteristics among studies comparing coronary computed tomography angiography to noninvasive functional testing in chronic coronary syndromesAlessandro Spirito, Alessandro Sticchi, Fabien Praz, et al.
Blood Pressure. Supplement|June 15, 2007
Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SRFranz Messerli, William H Frishman, William J Elliott, et al.
Stroke|January 7, 2006
Does the MOSES trial establish superiority of AT1-receptor blockers over dihydropyridine/calcium antagonists in secondary stroke prevention?Albert Fournier, Gabriel Choukroun, Santhi Samy Modeliar, et al.
Current Hypertension Reports|May 7, 2004
Is the angiotensin II Type 2 receptor cerebroprotective?Albert Fournier, Jean Michel Achard, Florent Boutitie, et al.
The American Journal of Cardiology|May 27, 2014
Meta-analysis of randomized clinical trials comparing short-term versus long-term dual antiplatelet therapy following drug-eluting stentsGeorges El-Hayek, Franz Messerli, Sripal Bangalore, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 26, 2013
High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trialsAlexandre M Benjo, Georges E El-Hayek, Franz Messerli, et al.
European Journal of Internal Medicine|May 9, 2026
Hypertension and blood pressure profiles in patients with acute intermittent porphyria: a prospective case-control studyKrzysztof Jaworski, Robert Wasilewski, Jerzy Windyga, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of the American Society of Hypertension : JASH|September 7, 2012
Ambulatory blood pressure monitoring should be included in the National Health and Nutritional Examination Survey (NHANES)Thomas D Giles, Henry R Black, Franz Messerli, et al.
Current Pharmaceutical Design|May 30, 2006
Target organ damage in hypertension: pathophysiology and implications for drug therapySunil K Nadar, Muzahir H Tayebjee, Franz Messerli, et al.
Hypertension (Dallas, Tex. : 1979)|July 4, 2007
Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril StudyGiuseppe Mancia, Franz Messerli, George Bakris, et al.
American Heart Journal|November 18, 2022
Impact of design characteristics among studies comparing coronary computed tomography angiography to noninvasive functional testing in chronic coronary syndromesAlessandro Spirito, Alessandro Sticchi, Fabien Praz, et al.
Blood Pressure. Supplement|June 15, 2007
Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SRFranz Messerli, William H Frishman, William J Elliott, et al.
Stroke|January 7, 2006
Does the MOSES trial establish superiority of AT1-receptor blockers over dihydropyridine/calcium antagonists in secondary stroke prevention?Albert Fournier, Gabriel Choukroun, Santhi Samy Modeliar, et al.
Current Hypertension Reports|May 7, 2004
Is the angiotensin II Type 2 receptor cerebroprotective?Albert Fournier, Jean Michel Achard, Florent Boutitie, et al.
The American Journal of Cardiology|May 27, 2014
Meta-analysis of randomized clinical trials comparing short-term versus long-term dual antiplatelet therapy following drug-eluting stentsGeorges El-Hayek, Franz Messerli, Sripal Bangalore, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 26, 2013
High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trialsAlexandre M Benjo, Georges E El-Hayek, Franz Messerli, et al.
European Journal of Internal Medicine|May 9, 2026
Hypertension and blood pressure profiles in patients with acute intermittent porphyria: a prospective case-control studyKrzysztof Jaworski, Robert Wasilewski, Jerzy Windyga, et al.
Pageof 3